PAR 13.7% 29.0¢ paradigm biopharmaceuticals limited..

AGM 2024 - QUESTIONS, page-47

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    The following changes made to the P3 trial suggests it was made at the request of the FDA. This could've also been the reason for the lengthy IND delays, the back and forth around use of 2 mg vs 1.5 mg. A real shame.
    https://classic.clinicaltrials.gov/ct2/history/NCT04809376?A=1&B=2&C=Side-by-Side#StudyPageTop


    https://hotcopper.com.au/data/attachments/5747/5747310-540a4442c6ccb5f9a823ad92d782604b.jpg

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
0.035(13.7%)
Mkt cap ! $101.4M
Open High Low Value Volume
25.5¢ 29.0¢ 25.0¢ $162.3K 595.5K

Buyers (Bids)

No. Vol. Price($)
2 49897 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 24504 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.